These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 18029386)

  • 1. Regulation of glycogen synthesis by the laforin-malin complex is modulated by the AMP-activated protein kinase pathway.
    Solaz-Fuster MC; Gimeno-Alcañiz JV; Ros S; Fernandez-Sanchez ME; Garcia-Fojeda B; Criado Garcia O; Vilchez D; Dominguez J; Garcia-Rocha M; Sanchez-Piris M; Aguado C; Knecht E; Serratosa J; Guinovart JJ; Sanz P; Rodriguez de Córdoba S
    Hum Mol Genet; 2008 Mar; 17(5):667-78. PubMed ID: 18029386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMP-activated protein kinase phosphorylates R5/PTG, the glycogen targeting subunit of the R5/PTG-protein phosphatase 1 holoenzyme, and accelerates its down-regulation by the laforin-malin complex.
    Vernia S; Solaz-Fuster MC; Gimeno-Alcañiz JV; Rubio T; García-Haro L; Foretz M; de Córdoba SR; Sanz P
    J Biol Chem; 2009 Mar; 284(13):8247-55. PubMed ID: 19171932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laforin, a dual-specificity phosphatase involved in Lafora disease, is phosphorylated at Ser25 by AMP-activated protein kinase.
    Romá-Mateo C; Solaz-Fuster Mdel C; Gimeno-Alcañiz JV; Dukhande VV; Donderis J; Worby CA; Marina A; Criado O; Koller A; Rodriguez De Cordoba S; Gentry MS; Sanz P
    Biochem J; 2011 Oct; 439(2):265-75. PubMed ID: 21728993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lafora disease proteins laforin and malin negatively regulate the HIPK2-p53 cell death pathway.
    Upadhyay M; Gupta S; Bhadauriya P; Ganesh S
    Biochem Biophys Res Commun; 2015 Aug; 464(1):106-11. PubMed ID: 26102034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into Lafora disease: malin is an E3 ubiquitin ligase that ubiquitinates and promotes the degradation of laforin.
    Gentry MS; Worby CA; Dixon JE
    Proc Natl Acad Sci U S A; 2005 Jun; 102(24):8501-6. PubMed ID: 15930137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laforin, the dual-phosphatase responsible for Lafora disease, interacts with R5 (PTG), a regulatory subunit of protein phosphatase-1 that enhances glycogen accumulation.
    Fernández-Sánchez ME; Criado-García O; Heath KE; García-Fojeda B; Medraño-Fernández I; Gomez-Garre P; Sanz P; Serratosa JM; Rodríguez de Córdoba S
    Hum Mol Genet; 2003 Dec; 12(23):3161-71. PubMed ID: 14532330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deciphering the role of malin in the lafora progressive myoclonus epilepsy.
    Romá-Mateo C; Sanz P; Gentry MS
    IUBMB Life; 2012 Oct; 64(10):801-8. PubMed ID: 22815132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of the autophagic PI3KC3 complex by laforin/malin E3-ubiquitin ligase, two proteins involved in Lafora disease.
    Sanchez-Martin P; Lahuerta M; Viana R; Knecht E; Sanz P
    Biochim Biophys Acta Mol Cell Res; 2020 Feb; 1867(2):118613. PubMed ID: 31758957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malin decreases glycogen accumulation by promoting the degradation of protein targeting to glycogen (PTG).
    Worby CA; Gentry MS; Dixon JE
    J Biol Chem; 2008 Feb; 283(7):4069-76. PubMed ID: 18070875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased endoplasmic reticulum stress and decreased proteasomal function in lafora disease models lacking the phosphatase laforin.
    Vernia S; Rubio T; Heredia M; Rodríguez de Córdoba S; Sanz P
    PLoS One; 2009 Jun; 4(6):e5907. PubMed ID: 19529779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lafora disease proteins malin and laforin are recruited to aggresomes in response to proteasomal impairment.
    Mittal S; Dubey D; Yamakawa K; Ganesh S
    Hum Mol Genet; 2007 Apr; 16(7):753-62. PubMed ID: 17337485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired malin expression and interaction with partner proteins in Lafora disease.
    Skurat AV; Segvich DM; Contreras CJ; Hu YC; Hurley TD; DePaoli-Roach AA; Roach PJ
    J Biol Chem; 2024 May; 300(5):107271. PubMed ID: 38588813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic depletion of the malin E3 ubiquitin ligase in mice leads to lafora bodies and the accumulation of insoluble laforin.
    DePaoli-Roach AA; Tagliabracci VS; Segvich DM; Meyer CM; Irimia JM; Roach PJ
    J Biol Chem; 2010 Aug; 285(33):25372-81. PubMed ID: 20538597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The laforin-malin complex negatively regulates glycogen synthesis by modulating cellular glucose uptake via glucose transporters.
    Singh PK; Singh S; Ganesh S
    Mol Cell Biol; 2012 Feb; 32(3):652-63. PubMed ID: 22124153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lafora progressive myoclonus epilepsy: NHLRC1 mutations affect glycogen metabolism.
    Couarch P; Vernia S; Gourfinkel-An I; Lesca G; Gataullina S; Fedirko E; Trouillard O; Depienne C; Dulac O; Steschenko D; Leguern E; Sanz P; Baulac S
    J Mol Med (Berl); 2011 Sep; 89(9):915-25. PubMed ID: 21505799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The laforin-malin complex, involved in Lafora disease, promotes the incorporation of K63-linked ubiquitin chains into AMP-activated protein kinase beta subunits.
    Moreno D; Towler MC; Hardie DG; Knecht E; Sanz P
    Mol Biol Cell; 2010 Aug; 21(15):2578-88. PubMed ID: 20534808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interdependence of laforin and malin proteins for their stability and functions could underlie the molecular basis of locus heterogeneity in Lafora disease.
    Mittal S; Upadhyay M; Singh PK; Parihar R; Ganesh S
    J Biosci; 2015 Dec; 40(5):863-71. PubMed ID: 26648032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased laforin and laforin binding to glycogen underlie Lafora body formation in malin-deficient Lafora disease.
    Tiberia E; Turnbull J; Wang T; Ruggieri A; Zhao XC; Pencea N; Israelian J; Wang Y; Ackerley CA; Wang P; Liu Y; Minassian BA
    J Biol Chem; 2012 Jul; 287(30):25650-9. PubMed ID: 22669944
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lafora Disease: A Ubiquitination-Related Pathology.
    García-Gimeno MA; Knecht E; Sanz P
    Cells; 2018 Jul; 7(8):. PubMed ID: 30050012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The laforin/malin E3-ubiquitin ligase complex ubiquitinates pyruvate kinase M1/M2.
    Viana R; Lujan P; Sanz P
    BMC Biochem; 2015 Oct; 16():24. PubMed ID: 26493215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.